Publications by authors named "M Bischof"

Claim this Profile
C
Cost-utility analysis of newborn screening for spinal muscular atrophy in Japan.
Akira Hata, Akihito Uda, Satoru Tanaka, Diana Weidlich, Walter Toro, Matthias Bischof

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands.
Simon van der Schans, Rimma Velikanova, Diana Weidlich, Ruth Howells, Anish Patel, Matthias Bischof

Eur J Health Econ· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).
Farastuk Bozorgmehr, Inn Chung, Jürgen R Fischer, Marc Bischof, Akin Atmaca

Clin Exp Metastasis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals.
Ian R Woodcock, Didu S Kariyawasam, Maina P Kava, Eppie M Yiu, Damian Clark, Matthias Bischof

Neurol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy.
Ilaria Valentini, Gianni Ghetti, Marika Pane, Filippo Rumi, Eugenio Di Brino, Matthias Bischof

Eur J Health Econ· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis